Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay M Lee

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
The Annals of Thoracic Surgery|August 2, 2021
Surgical Perspective on Neoadjuvant Immunotherapy in Non-Small Cell Lung CancerJay M Lee, Masahiro Tsuboi, Alessandro Brunelli
JAMA|October 11, 2018
The Evolving Epidemiology and Management of Spontaneous PneumothoraxEric Savitsky, Scott S Oh, Jay M Lee
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Updates in Local-Regionally Advanced Non-Small Cell Lung CancerAnne S Tsao, Shruti Jolly, Jay M Lee
Seminars in Thoracic and Cardiovascular Surgery|January 4, 2020
Discussions in Cardiothoracic Treatment and Care: What the Surgeon Needs to Know About Checkpoint Inhibition in ImmunotherapyJay M Lee, Linda W Martin, Stephen C Yang
Future Oncology (London, England)|March 27, 2007
Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of NSCLCJay M Lee, Jenny T Mao, Kostyantyn Krysan, et al.
Cancer Journal (Sudbury, Mass.)|August 10, 2010
Chemokines: can effector cells be redirected to the site of the tumor?Steven M Dubinett, Jay M Lee, Sherven Sharma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumorsJay M Lee, Ali Mahtabifard, Reiko Yamada, et al.
Future Oncology (London, England)|August 25, 2022
Overcoming immunosuppression and pro-tumor inflammation in lung cancer with combined IL-1β and PD-1 inhibitionJay M Lee, Masahiro Tsuboi, Edward S Kim, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
Updates on the Perioperative Management of Resectable Non-Small Cell Lung CancerStacey M Frumm, Narjust Florez, Jay M Lee, et al.
JTO Clinical and Research Reports|April 3, 2023
Economic Burden of Recurrence Among Resected Medicare Patients With Early Stage NSCLCJay M Lee, Rongrong Wang, Ann Johnson, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
The Annals of Thoracic Surgery|August 2, 2021
Surgical Perspective on Neoadjuvant Immunotherapy in Non-Small Cell Lung CancerJay M Lee, Masahiro Tsuboi, Alessandro Brunelli
JAMA|October 11, 2018
The Evolving Epidemiology and Management of Spontaneous PneumothoraxEric Savitsky, Scott S Oh, Jay M Lee
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Updates in Local-Regionally Advanced Non-Small Cell Lung CancerAnne S Tsao, Shruti Jolly, Jay M Lee
Seminars in Thoracic and Cardiovascular Surgery|January 4, 2020
Discussions in Cardiothoracic Treatment and Care: What the Surgeon Needs to Know About Checkpoint Inhibition in ImmunotherapyJay M Lee, Linda W Martin, Stephen C Yang
Future Oncology (London, England)|March 27, 2007
Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of NSCLCJay M Lee, Jenny T Mao, Kostyantyn Krysan, et al.
Cancer Journal (Sudbury, Mass.)|August 10, 2010
Chemokines: can effector cells be redirected to the site of the tumor?Steven M Dubinett, Jay M Lee, Sherven Sharma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumorsJay M Lee, Ali Mahtabifard, Reiko Yamada, et al.
Future Oncology (London, England)|August 25, 2022
Overcoming immunosuppression and pro-tumor inflammation in lung cancer with combined IL-1β and PD-1 inhibitionJay M Lee, Masahiro Tsuboi, Edward S Kim, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
Updates on the Perioperative Management of Resectable Non-Small Cell Lung CancerStacey M Frumm, Narjust Florez, Jay M Lee, et al.
JTO Clinical and Research Reports|April 3, 2023
Economic Burden of Recurrence Among Resected Medicare Patients With Early Stage NSCLCJay M Lee, Rongrong Wang, Ann Johnson, et al.
Pageof 10